Cataract Surgery and MIGS

Yes, MIGS is typically performed concurrently with cataract surgery. Since we're already in the eye and 'in the neighborhood' of the eye's natural drainage system, MIGS microstents can be placed right after the intraocular lens (IOL). This integrated approach saves time and minimizes the patient's overall impact, resulting in a smoother and more efficient treatment process.

While it may start working immediately, we generally wait to assess the effects of MIGS about 1 to 3 months following surgery. Until then, Dr. Raviv will have you continue your regular glaucoma drops and post-op drops. After completing the post-op drops in one month, decisions about stopping one or more of your glaucoma drops can be made. MIGS is not a cure for glaucoma but rather a treatment to help manage the disease and potentially reduce the number and frequency of glaucoma medications. We will closely monitor your progress during follow-up appointments to assess the procedure's effectiveness and make any necessary adjustments to your treatment plan.

Some patients may be able to reduce or eliminate their use of glaucoma medications, while others may still require some level of medication to control their intraocular pressure.

ORA intraoperative aberrometry is a valuable tool for enhancing the accuracy and precision of cataract surgery, particularly in cases where preoperative measurements may be unreliable or inconclusive. While the technology can benefit a wide range of patients, its utility may be particularly significant in complex cases such as post-LASIK or other unusual situations where traditional methods of IOL selection may be challenging. During your preoperative evaluation, Dr. Raviv will determine if ORA aberrometry is appropriate for your specific needs and recommend the most suitable treatment plan.